Nobuyuki Koyama
9PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 16, 2026
Association of Immune-Related Adverse Events and the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Adjusting for Immortal Time Bias.Yoshiki Kuwabara, Hiroyuki Ohya, Maiko Osawa
|Mar 02, 2026
Effects of Autophagy Inhibition by SAR405, a Selective VPS34 Inhibitor, on Pleural Mesothelioma Cells.Yoshiki Kuwabara, Kosuke Sakai, Kota Shiraishi
|Jan 27, 2026
Discrepant CD3+ TILs in PD-L1-Negative NSCLC: Favorable Outcome in an Elderly Patient Treated With Nivolumab, Ipilimumab, and Chemotherapy.Mataichi Sekiya, Munehide Nakatsugawa, Nobuyuki Koyama
|Sep 10, 2025
Efficacy of Immune Checkpoint Inhibitors in Combination With Platinum-Based Doublet Chemotherapy for Extensive-Stage Small-Cell Lung Cancer Patients With Eastern Cooperative Oncology Group-Performance Status 2-3: A Single-Institution Retrospective Study.Kosuke Sakai, Shigeru Ishii, Shin Yokosuka
|Oct 14, 2024
miR-4448/Girdin/Akt/AMPK axis inhibits EZH2-mediated EMT and tumorigenesis in small-cell lung cancer.Nobuyuki Koyama, Yuichi Ishikawa, Hiromitsu Ohta
|Apr 18, 2020
Pulmonary mucoepidermoid carcinoma arising in a patient with Kartagener syndrome.Yoshiaki Nagai, Nobuyuki Koyama, Yuki Iwai
Pageof 2
